Victoria S. Rashbrook
Roosevelt Drive
Oxford, ENG, United Kingdom
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CreER activation transiently disrupts angiogenesis by reducing proliferation and promoting apoptosis in vascular endothelial cells.
Journal: Angiogenesis
Published: May 22, 2025
Mutagenesis on a complex mouse genetic background by site-specific nucleases.
Journal: Transgenic research
Published: October 27, 2023
Cre toxicity in mouse models of cardiovascular physiology and disease.
Journal: Nature cardiovascular research
Published: September 11, 2023
Tamoxifen exacerbates morbidity and mortality in male mice receiving medetomidine anaesthesia.
Journal: Animal welfare (South Mimms, England)
Published: April 04, 2023
PHACTR1 modulates vascular compliance but not endothelial function: a translational study.
Journal: Cardiovascular research
Published: December 01, 2021
Tamoxifen-Activated CreERT Impairs Retinal Angiogenesis Independently of Gene Deletion.
Journal: Circulation research
Published: July 09, 2020
A key role for the novel coronary artery disease gene JCAD in atherosclerosis via shear stress mechanotransduction.
Journal: Cardiovascular research
Published: August 09, 2019
Endothelial Cell Tetrahydrobiopterin Modulates Sensitivity to Ang (Angiotensin) II-Induced Vascular Remodeling, Blood Pressure, and Abdominal Aortic Aneurysm.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: March 21, 2018
Roles for endothelial cell and macrophage Gch1 and tetrahydrobiopterin in atherosclerosis progression.
Journal: Cardiovascular research
Published: August 10, 2017
Human venous valve disease caused by mutations in FOXC2 and GJC2.
Journal: The Journal of experimental medicine
Published: June 08, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026